Mirabegron ER Tablets 25mg, 50mg

What is Mirabegron ER Tablets 25mg, 50mg?

Mirabegron ER Tablets are extended-release oral tablets available in 25 mg and 50 mg strengths. Mirabegron is used for the management of overactive bladder symptoms, including urinary urgency, increased urinary frequency, and urge urinary incontinence. The extended-release formulation is designed to provide prolonged release of the active ingredient according to the approved product information.

Uses / Indications

Mirabegron ER Tablets may be used for the management of overactive bladder symptoms, including:

• Urinary urgency
• Increased urinary frequency
• Urge urinary incontinence
• Symptoms associated with overactive bladder

The appropriate strength and indication should be determined according to the approved product information and healthcare professional guidance.

Benefits

• Provides mirabegron in an extended-release oral tablet formulation.
• Available in 25 mg and 50 mg strengths.
• Used for management of common overactive bladder symptoms.
• Provides a non-antimuscarinic pharmacological approach to overactive bladder management.
• Supplied in Alu-Alu blister packaging for pharmaceutical supply requirements.

Side Effects

Common Side Effects

Possible side effects may include:

• Increased blood pressure
• Headache
• Nasopharyngitis
• Urinary tract infection
• Constipation
• Dizziness
• Nausea

Less Common or Serious Side Effects

Less common but potentially serious effects may include significant increases in blood pressure, urinary retention, abnormal heart-related symptoms, or hypersensitivity reactions.

Seek prompt medical attention if severe allergic reactions, inability to urinate, significant palpitations, or other serious symptoms occur.

How Does It Work?

Mirabegron is a beta-3 adrenergic receptor agonist. It stimulates beta-3 receptors in the detrusor muscle of the urinary bladder, promoting relaxation during the bladder storage phase. This can increase functional bladder capacity and help reduce symptoms such as urgency, increased urinary frequency, and urge urinary incontinence.

Dosage Guidelines

The appropriate strength and treatment regimen depend on the patient’s symptoms, response to treatment, kidney and liver function, age, and other medicines being used.

The exact dose and treatment duration should follow the approved product information and the recommendation of a qualified healthcare professional.

For oral extended-release tablets:

• Take exactly as prescribed.
• Swallow the tablet whole with water.
• Do not crush, chew, or split the extended-release tablet unless specifically permitted by the approved product information.
• Follow the prescribed dosing schedule consistently.
• Do not change from 25 mg to 50 mg without professional guidance.

If an overdose is suspected, seek immediate medical attention or contact an appropriate poison-control or emergency medical service.

When Not to Use

Mirabegron ER Tablets should not be used in individuals with a known hypersensitivity to mirabegron or any ingredient in the approved formulation.

Particular caution or medical assessment may be required in individuals with uncontrolled high blood pressure, urinary retention, bladder outlet obstruction, or certain kidney or liver conditions.

Drug / Product Interactions

Mirabegron may interact with certain medicines and can affect the exposure of medicines metabolized through specific metabolic pathways.

Important interaction considerations may include:

• Medicines metabolized through CYP2D6
• Certain medicines with a narrow therapeutic range
• Other medicines that may increase blood pressure
• Medicines affecting heart rhythm
• Other medicines requiring dose adjustment when combined with mirabegron

A complete medication list should be reviewed by a qualified healthcare professional before treatment.

Safety Advice

• Blood pressure should be assessed before and during treatment where clinically appropriate.
• Inform the healthcare professional about hypertension or cardiovascular conditions.
• Tell the healthcare professional if there is difficulty emptying the bladder or a history of urinary retention.
• Inform the healthcare professional about kidney or liver disease.
• Review all current prescription medicines, non-prescription medicines, and supplements for possible interactions.
• Seek immediate medical attention for severe allergic reactions, inability to urinate, or significant cardiovascular symptoms.

General Instructions

• Take the tablet exactly as prescribed.
• Swallow the extended-release tablet whole with water.
• Do not crush, chew, or split the tablet unless specifically allowed by the approved product information.
• Take the medicine according to the prescribed schedule.
• Do not change the strength or discontinue treatment without appropriate professional advice.
• Keep the medicine out of reach of children.

Special Dietary / Lifestyle Tips

No specific diet is required solely because of mirabegron treatment unless advised otherwise by a healthcare professional.

For overactive bladder symptoms, individuals may benefit from appropriate fluid management, regular physical activity, bladder-training strategies, and limiting excessive consumption of beverages that may aggravate urinary symptoms, such as caffeinated drinks.

Comparison with Other Treatments

Mirabegron is a beta-3 adrenergic receptor agonist used for overactive bladder management. Other treatment options may include antimuscarinic medicines, combination pharmacotherapy, bladder-training measures, pelvic-floor interventions, or other approaches depending on the patient’s symptoms and clinical condition.

Treatment selection depends on the diagnosis, symptom severity, previous treatment response, tolerability, medical history, and approved treatment recommendations.

Precautions & Warnings

• Monitor blood pressure where clinically appropriate.
• Use caution in patients with significant hypertension.
• Inform the healthcare professional about urinary retention or bladder outlet obstruction.
• Kidney and liver function may affect treatment considerations.
• Review potential interactions with medicines metabolized through relevant pathways.
• Seek medical attention if severe urinary retention or significant cardiovascular symptoms develop.
• Use during pregnancy or breastfeeding only according to appropriate professional advice and approved product information.

Can I Use It With Other Medicines?

Generally Compatible With

Mirabegron may be used with other medicines when specifically prescribed and reviewed by a qualified healthcare professional.

Use With Caution / Avoid

Particular caution may be required with CYP2D6 substrate medicines, medicines affecting blood pressure, and other products for which mirabegron may alter systemic exposure.

Patients should provide a complete list of medicines and supplements before starting treatment.

Storage

Store according to the storage conditions stated on the approved product label and package insert.

• Keep the tablets in their original packaging.
• Protect from excessive heat and moisture.
• Keep the blister properly stored until use.
• Keep out of reach of children.
• Do not use after the expiry date.

Frequently Asked Questions

1. What are Mirabegron ER Tablets used for?

Mirabegron ER Tablets are used for the management of overactive bladder symptoms such as urinary urgency, increased urinary frequency, and urge urinary incontinence.

2. What strengths are available?

The stated strengths are Mirabegron ER 25 mg and Mirabegron ER 50 mg.

3. What does ER mean in Mirabegron ER?

ER means extended release, indicating that the formulation is designed to release mirabegron over an extended period following oral administration.

4. How does mirabegron work?

Mirabegron stimulates beta-3 adrenergic receptors in the bladder detrusor muscle, promoting relaxation during the storage phase and helping manage overactive bladder symptoms.

5. Can Mirabegron ER Tablets affect blood pressure?

Mirabegron can increase blood pressure in some individuals. Blood pressure considerations should therefore be discussed with a qualified healthcare professional.

6. Can the extended-release tablet be crushed or chewed?

The tablet should generally be swallowed whole. It should not be crushed, chewed, or split unless specifically permitted by the approved product information.

7. What are common side effects of mirabegron?

Possible side effects include increased blood pressure, headache, nasopharyngitis, urinary tract infection, constipation, dizziness, and nausea.

8. How should Mirabegron ER Tablets be stored?

Store according to the approved product label and package insert, protecting the tablets from excessive heat and moisture and keeping them out of reach of children.